Showing results (161-170 of 235) with videos related to
Sort By:
Pageof 24
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2024
Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate CancerW Robert Lee, James J Dignam, Mahul B Amin, et al.Practical Radiation Oncology|January 7, 2018
A multi-institutional phase 2 trial of prostate stereotactic body radiation therapy (SBRT) using continuous real-time evaluation of prostate motion with patient-reported quality of lifeWilliam C Jackson, Robert T Dess, Dale W Litzenberg, et al.International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202Colleen A F Lawton, Xiaolei Lin, Gerald E Hanks, et al.The Journal of Urology|September 6, 2016
Relief of Urinary Symptom Burden after Primary Prostate Cancer TreatmentPeter Chang, Meredith M Regan, Montserrat Ferrer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2023
Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional TrialDaniel J Krauss, Theodore Karrison, Alvaro A Martinez, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2025
Emerin Dysregulation Drives the Very-Small-Nuclear Phenotype and Lineage Plasticity That Associate with a Clinically Aggressive Subtype of Prostate CancerLe Zhang, Pai-Chi Teng, Karen A Cavassani, et al.European Urology Oncology|July 13, 2023
Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily IrradiationDouglas M Dahl, Theodore G Karrison, M Dror Michaelson, et al.International Journal of Radiation Oncology, Biology, Physics|April 9, 2019
Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical TrialsChristopher L Hallemeier, Peixin Zhang, Thomas M Pisansky, et al.Journal of the National Cancer Institute|March 21, 2022
Quantitative Nodal Burden and Mortality Across Solid CancersAnthony T Nguyen, Michael Luu, Vina P Nguyen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2023
Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical TrialJeff M Michalski, Kathryn A Winter, Bradley R Prestidge, et al.Pageof 24